UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells

Frontiers in oncology, 2023-05, Vol.13, p.1203470-1203470

2023

Volltextzugriff (PDF)

Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD

Frontiers in oncology, 2024-09, Vol.14, p.1419118

2024

Volltextzugriff (PDF)

Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy

Frontiers in immunology, 2024-05, Vol.15, p.1393485

2024

Volltextzugriff (PDF)

A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency

Current oncology (Toronto), 2022-12, Vol.30 (1), p.274-283

2022

Volltextzugriff (PDF)

Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience

Frontiers in oncology, 2024, Vol.14, p.1370405-1370405

2024

Volltextzugriff (PDF)

Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases

Current oncology (Toronto), 2022-02, Vol.29 (3), p.1455-1460

2022

Volltextzugriff (PDF)

P1075: ADVANCED‐STAGE CHL INTERNATIONAL PROGNOSTICATION INDEX: EXTERNAL VALIDATION IN A SINGLE‐CENTER RETROSPECTIVE PATIENT DATASET AND COMPARISON TO THE HASENCLEVER IPS

HemaSphere, 2023-08, Vol.7 (S3), p.e132523d-n/a

2023

Volltextzugriff (PDF)

P005: Age, histotype and stage IV are associated with a shorter survival in patients with Hodgkin lymphoma, even the PET‐adapted era. A single center retrospective study

HemaSphere, 2022-10, Vol.6 (Suppl), p.3-3

2022

Volltextzugriff (PDF)

P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma

HemaSphere, 2022-10, Vol.6 (Suppl), p.24-24

2022

Volltextzugriff (PDF)

Multiple specialized stem cell niches characterize hematopoiesis in the human fetal liver

Journal of pediatric and neonatal individualized medicine, 2020-04, Vol.9 (1), p.e090118-e090118

2020

Volltextzugriff (PDF)

Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax‐based regimens

British journal of haematology, 2024-07, Vol.205 (1), p.189-193

2024

Volltextzugriff (PDF)

Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness

British journal of haematology, 2023-10, Vol.203 (2), p.224-236

2023

Volltextzugriff (PDF)

Serum Soluble Interleukin-2 Receptor Levels in Hairy Cell Leukemia As a Marker of Tumor Burden with Prognostic Value and As a Tool for Disease Monitoring

Blood, 2023-11, Vol.142 (Supplement 1), p.4414-4414

2023

Volltextzugriff (PDF)

Pre‐exposure prophylaxis with tixagevimab/cilgavimab in patients with chronic lymphocytic leukaemia treated with targeted agents

British journal of haematology, 2023-05, Vol.201 (3), p.564-567

2023

Volltextzugriff (PDF)

From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance

Cancers, 2022-03, Vol.14 (6), p.1562

2022

Volltextzugriff (PDF)

Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course

Cancers, 2024-03, Vol.16 (6), p.1095

2024

Volltextzugriff (PDF)

Patients with Chronic Lymphocytic Leukemia Carrying t(14;19) Display a Distinctive Transcriptomic Profile and Adverse Outcome, Which Might be Overcome Continuous Therapy with BTK Inhibitors. an Italian Campus CLL and Eric Study

Blood, 2023-11, Vol.142 (Supplement 1), p.3275-3275

2023

Volltextzugriff (PDF)

PEDOT-CNT-Coated Low-Impedance, Ultra-Flexible, and Brain-Conformable Micro-ECoG Arrays

IEEE transactions on neural systems and rehabilitation engineering, 2015-05, Vol.23 (3), p.342-350

2015

Volltextzugriff (PDF)

A 5 pJ/pulse at 1-Gpps Pulsed Transmitter Based on Asynchronous Logic Master-Slave PLL Synthesis

IEEE transactions on circuits and systems. I, Regular papers, 2018-03, Vol.65 (3), p.1096-1109

2018

Volltextzugriff (PDF)

Independent Component Decomposition of Human Somatosensory Evoked Potentials Recorded by Micro-Electrocorticography

International journal of neural systems, 2017-06, Vol.27 (4), p.1650052

2017

Volltextzugriff (PDF)

Ultra-flexible and brain-conformable micro-electrocorticography device with low impedance PEDOT-carbon nanotube coated microelectrodes

2013 6th International IEEE/EMBS Conference on Neural Engineering (NER), 2013, p.927-930

2013

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)
Tagungsberichte
(1)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(17)
Oncology
(9)
Chronic Lymphocytic Leukemia
(7)
Humans
(7)
Hematology
(5)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(5)
Male
(4)
Technology
(4)
Venetoclax
(4)
Engineering
(3)
Ibrutinib
(3)
Microelectrodes
(3)
Adult
(2)
Aged
(2)
Antigens
(2)
Antineoplastic Agents - Therapeutic Use
(2)
Apoptosis
(2)
Bridged Bicyclo Compounds, Heterocyclic - Therapeutic Use
(2)
Engineering, Biomedical
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

4 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells

Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD

Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy

A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency

Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience

Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies

Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study

Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases

P1075: ADVANCED‐STAGE CHL INTERNATIONAL PROGNOSTICATION INDEX: EXTERNAL VALIDATION IN A SINGLE‐CENTER RETROSPECTIVE PATIENT DATASET AND COMPARISON TO THE HASENCLEVER IPS

P005: Age, histotype and stage IV are associated with a shorter survival in patients with Hodgkin lymphoma, even the PET‐adapted era. A single center retrospective study

P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma

Multiple specialized stem cell niches characterize hematopoiesis in the human fetal liver

Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax‐based regimens

Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness

Serum Soluble Interleukin-2 Receptor Levels in Hairy Cell Leukemia As a Marker of Tumor Burden with Prognostic Value and As a Tool for Disease Monitoring

Pre‐exposure prophylaxis with tixagevimab/cilgavimab in patients with chronic lymphocytic leukaemia treated with targeted agents

From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance

Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course

Patients with Chronic Lymphocytic Leukemia Carrying t(14;19) Display a Distinctive Transcriptomic Profile and Adverse Outcome, Which Might be Overcome Continuous Therapy with BTK Inhibitors. an Italian Campus CLL and Eric Study

Continuous venetoclax in treatment‐naive TP 53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study

Continuous venetoclax in treatment‐naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study

PEDOT-CNT-Coated Low-Impedance, Ultra-Flexible, and Brain-Conformable Micro-ECoG Arrays

A 5 pJ/pulse at 1-Gpps Pulsed Transmitter Based on Asynchronous Logic Master-Slave PLL Synthesis

Independent Component Decomposition of Human Somatosensory Evoked Potentials Recorded by Micro-Electrocorticography

Ultra-flexible and brain-conformable micro-electrocorticography device with low impedance PEDOT-carbon nanotube coated microelectrodes

Suchergebnisse filtern